Kim, Michelle M

Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical Trial. [electronic resource] - Translational oncology Apr 2016 - 108-113 p. digital

Publication Type: Journal Article

1936-5233

10.1016/j.tranon.2015.12.003 doi